TOMASSI, STEFANO
 Distribuzione geografica
Continente #
AS - Asia 1.340
EU - Europa 879
NA - Nord America 855
SA - Sud America 213
AF - Africa 49
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 3.338
Nazione #
US - Stati Uniti d'America 828
SG - Singapore 729
RU - Federazione Russa 512
CN - Cina 293
BR - Brasile 177
IT - Italia 176
HK - Hong Kong 116
VN - Vietnam 111
DE - Germania 34
CI - Costa d'Avorio 28
GB - Regno Unito 25
IN - India 24
NL - Olanda 23
KR - Corea 18
FI - Finlandia 16
AT - Austria 12
BG - Bulgaria 12
AR - Argentina 11
CA - Canada 11
FR - Francia 11
MX - Messico 11
IE - Irlanda 10
BD - Bangladesh 9
EC - Ecuador 9
PL - Polonia 9
UA - Ucraina 9
ID - Indonesia 8
IQ - Iraq 8
SE - Svezia 8
JP - Giappone 7
CO - Colombia 6
BE - Belgio 5
HR - Croazia 5
MA - Marocco 5
TR - Turchia 4
ZA - Sudafrica 4
CL - Cile 3
EG - Egitto 3
ES - Italia 3
PY - Paraguay 3
GR - Grecia 2
IR - Iran 2
NI - Nicaragua 2
PK - Pakistan 2
TW - Taiwan 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AU - Australia 1
BB - Barbados 1
CH - Svizzera 1
CW - ???statistics.table.value.countryCode.CW??? 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GH - Ghana 1
JM - Giamaica 1
JO - Giordania 1
KE - Kenya 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MZ - Mozambico 1
NE - Niger 1
NG - Nigeria 1
NP - Nepal 1
PE - Perù 1
PT - Portogallo 1
QA - Qatar 1
SA - Arabia Saudita 1
SD - Sudan 1
TN - Tunisia 1
VE - Venezuela 1
ZM - Zambia 1
Totale 3.338
Città #
Singapore 355
Chandler 143
Moscow 116
Hong Kong 115
Beijing 98
Ashburn 72
Hefei 71
Santa Clara 65
Millbury 31
Ho Chi Minh City 29
Naples 28
Los Angeles 25
Boston 22
Des Moines 22
Lawrence 22
Napoli 22
Dong Ket 20
Dallas 19
Amsterdam 18
Buffalo 16
Hanoi 16
São Paulo 16
Redondo Beach 15
Seoul 15
The Dalles 13
Munich 12
Sofia 12
Wilmington 12
Milan 11
Nanjing 11
Kochi 9
Princeton 9
Tianjin 9
Warsaw 9
Nuremberg 7
Ottawa 7
Porto Alegre 7
Stockholm 7
Tokyo 7
Chicago 6
Mexico City 6
New York 6
Ninh Bình 6
Seattle 6
Amorosi 5
Belo Horizonte 5
Brooklyn 5
Florence 5
Ha Long 5
Turku 5
Vienna 5
Zagreb 5
Biên Hòa 4
Brussels 4
Caserta 4
Lappeenranta 4
London 4
Piombino 4
Ribeirão Preto 4
Rio de Janeiro 4
Rome 4
Shanghai 4
Ankara 3
Baghdad 3
Can Tho 3
Charlotte 3
Chennai 3
Dhaka 3
Düsseldorf 3
Frankfurt am Main 3
Guayaquil 3
Haiphong 3
Hebei 3
Hải Dương 3
Manchester 3
Nanchang 3
Norwalk 3
Phoenix 3
Querétaro 3
Quito 3
Redwood City 3
Serra 3
Suzhou 3
São José 3
Woodbridge 3
Anzio 2
Ardabil 2
Athens 2
Battipaglia 2
Bologna 2
Brasília 2
Cao Bằng 2
Caxias do Sul 2
Changsha 2
Chengdu 2
Contagem 2
Curitiba 2
Fairfield 2
Florianópolis 2
Garching 2
Totale 1.722
Nome #
Click-Chemistry (CuAAC) Trimerization of an αvβ6 Integrin Targeting Ga-68-Peptide: Enhanced Contrast for in-Vivo PET Imaging of Human Lung Adenocarcinoma Xenografts 140
Exploring the N-Terminal Region of C-X-C Motif Chemokine 12 (CXCL12): Identification of Plasma-Stable Cyclic Peptides As Novel, Potent C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonists 127
Structure-Activity Relationships and Biological Characterization of a Novel, Potent, and Serum Stable C-X-C Chemokine Receptor Type 4 (CXCR4) Antagonist 115
From a Helix to a Small Cycle: Metadynamics-Inspired αvβ6 Integrin Selective Ligands 108
Disulfide bond replacement with 1,4‐ and 1,5‐disubstituted [1,2,3]‐triazole on C‐X‐C chemokine receptor type 4 (CXCR4) peptide ligands: small changes that make big differences 108
A combined approach of structure‐based virtual screening and NMR to interrupt the PD‐1/PD‐L1 axis: Biphenyl‐benzimidazole containing compounds as novel PD‐L1 inhibitors 107
Ligand-Based NMR Study of C-X-C Chemokine Receptor Type 4 (CXCR4)-Ligand Interactions on Living Cancer Cells 106
Boosting Fmoc Solid-Phase Peptide Synthesis by Ultrasonication 100
HOPPI-NMR: Hot-Peptide-Based Screening Assay for Inhibitors of Protein-Protein Interactions by NMR 96
Simultaneous Targeting of RGD-Integrins and Dual Murine Double Minute Proteins in Glioblastoma Multiforme 95
Properly Substituted Cyclic Bis-(2-bromobenzylidene) Compounds Behaved as Dual p300/CARM1 Inhibitors and Induced Apoptosis in Cancer Cells 94
Combined HAT/EZH2 modulation leads to cancer-selective cell death 94
Identification of PR-SET7 and EZH2 selective inhibitors inducing cell death in human leukemia U937 cells 91
Quinoline-Based p300 Histone Acetyltransferase Inhibitors with Pro-apoptotic Activity in Human Leukemia U937 Cells 90
Halting the Spread of Herpes Simplex Virus-1: The Discovery of an Effective Dual αvβ6/αvβ8 Integrin Ligand 89
Investigation of the stereochemical-dependent DNA and RNA binding of arginine-based nucleopeptides 87
Switchable Protecting Strategy for Solid Phase Synthesis of DNA and RNA Interacting Nucleopeptides 84
Indazole-Based Covalent Inhibitors To Target Drug-Resistant Epidermal Growth Factor Receptor. 81
Characterization of water-soluble esters of nitrobenzoxadiazole-based GSTP1-1 inhibitors for cancer treatment 81
A novel smaller β‐defensin‐derived peptide is active against multidrug‐resistant bacterial strains 81
Pan-Histone Demethylase Inhibitors Simultaneously Targeting Jumonji C and Lysine-Specific Demethylases Display High Anticancer Activities 80
Discovery of Pyrido[3′,2′:5,6]thiopyrano[4,3‐d]pyrimidine-Based Antiproliferative Multikinase Inhibitors 80
Targeting Drug Resistance in EGFR with Covalent Inhibitors: A Structure-Based Design Approach 77
New insights in the structure-activity relationships of 2-phenylamino-substituted benzothiopyrano[4,3-d]pyrimidines as kinase inhibitors 77
From PARP1 to TNKS2 Inhibition: A Structure-Based Approach 77
The organometallic ferrocene exhibits amplified anti-tumor activity by targeted delivery via highly selective ligands to αvβ3, αvβ6, or α5β1 integrins 77
First-in-Class Selective Inhibitors of the Lysine Acetyltransferase KAT8 76
Phenotypic Identification of a Novel Autophagy Inhibitor Chemotype Targeting Lipid Kinase VPS34 74
Novel reversible monoamine oxidase A inhibitors: highly potent and selective 3-(1H-pyrrol-3-yl)-2-oxazolidinones 73
Novel Peptide-Based PET Probe for Non-invasive Imaging of C-X-C Chemokine Receptor Type 4 (CXCR4) in Tumors 70
Specific Inhibitors of Mitochondrial Deacylase Sirtuin 4 Endowed with Cellular Activity 65
Ultrasound-assisted Peptide Nucleic Acids synthesis (US-PNAS) 61
Design and synthesis of Nrf2-derived hydrocarbon stapled peptides for the disruption of protein-DNA-interactions 60
Cationic nucleopeptides as novel non-covalent carriers for the delivery of peptide nucleic acid (PNA) and RNA oligomers 57
CLIPSing Melanotan-II to Discover Multiple Functionally Selective hMCR Agonists 56
Antitumor efficacy of Kisspeptin in human malignant mesothelioma cells 54
Novel non-covalent LSD1 inhibitors endowed with anticancer effects in leukemia and solid tumor cellular models 53
Disulfide bond replacement with non-reducible side chain to tail macrolactamization for the development of potent and selective CXCR4 peptide antagonists endowed with flanking binding sites 50
Tailoring the Structure of Cell Penetrating DNA and RNA Binding Nucleopeptides 49
tert-Butylcarbamate-Containing Histone Deacetylase Inhibitors: Apoptosis Induction, Cytodifferentiation, and Antiproliferative Activities in Cancer Cells 46
Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells 46
Polycomb Repressive Complex 2 Modulation through the Development of EZH2-EED Interaction Inhibitors and EED Binders 44
Switching Roles─Exploring Concentration-Dependent Agonistic versus Antagonistic Behavior of Integrin Ligands 39
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cells 33
Totale 3.448
Categoria #
all - tutte 11.412
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 11.412


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202185 0 0 0 0 0 33 6 4 0 2 12 28
2021/2022169 2 0 2 1 6 19 5 9 12 13 24 76
2022/2023301 37 22 21 11 42 45 2 36 48 20 11 6
2023/2024188 8 30 12 9 5 14 12 39 9 3 34 13
2024/20251.177 56 105 5 15 13 93 136 71 65 124 398 96
2025/20261.338 228 242 245 217 367 39 0 0 0 0 0 0
Totale 3.448